- R Baltussen, senior researcher1,
- A Smith, honorary professor2,
- D Chisholm, health economist3
- 1Department of Primary and Community Care, Radboud University, Nijmegen Medical Centre, Netherlands
- 2International Centre for Evidence on Disability, London School of Hygiene and Tropical Medicine, London, UK
- 3Department of Health Systems Financing, WHO, Geneva, Switzerland
- r.baltussen{at}elg.umcn.nl
Solomon and colleagues inappropriately label our analysis of trachoma control erroneous, but their comments are largely related to methodological issues in (standardised WHO-CHOICE) cost effectiveness analysis and present gaps in knowledge.1 2
Firstly, mass treatment with antibiotics of all residents is probably more effective and costly than treatment of children. Whether the first intervention is cost effective according to international thresholds, and more cost effective …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking